Can-Fite to Deliver 2 Presentations on its Cancer Drug CF102 at the 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine on October 8-10, 2015 in Athens
October 07, 2015 at 07:04 AM EDT
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) today announced the Company's Director of Molecular Biology Labs, Shira Cohen, will deliver ...